Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer

Author:

Almahli Hadia,Hadchity Elie,Jaballah Maiy Y.,Daher Racha,Ghabbour Hazem A.,Kabil Maha M.,Al-shakliah Nasser S.,Eldehna Wagdy M.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference48 articles.

1. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship, Mayo Clinic proceedings;Molina;Mayo Clinic,2008

2. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed.: American college of chest physicians evidence-based clinical practice guidelines;Alberg;Chest,2013

3. PARP inhibition: PARP1 and beyond, Nature reviews;Rouleau;Cancer,2010

4. Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer;Comen;Oncology (Williston Park, N.Y.),2010

5. Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology;Ratnam;Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3